Skip to main content

Published locations for FDA approves abiraterone use ahead of prostate cancer chemotherapy

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves abiraterone use ahead of prostate cancer chemotherapy

User login

  • Reset your password
  • /content/fda-approves-abiraterone-use-ahead-prostate-cancer-chemotherapy
  • /familypracticenews/article/57010/genitourinary-cancer/fda-approves-abiraterone-use-ahead-prostate
  • /internalmedicinenews/article/57010/genitourinary-cancer/fda-approves-abiraterone-use-ahead-prostate
  • /oncologypractice/article/57010/genitourinary-cancer/fda-approves-abiraterone-use-ahead-prostate
  • /clinicalendocrinologynews/article/57010/genitourinary-cancer/fda-approves-abiraterone-use-ahead
  • /hematology-oncology/article/57010/genitourinary-cancer/fda-approves-abiraterone-use-ahead-prostate
  • /endocrinology/article/57010/genitourinary-cancer/fda-approves-abiraterone-use-ahead-prostate-cancer
  • /internalmedicine/article/57010/genitourinary-cancer/fda-approves-abiraterone-use-ahead-prostate
  • /familymedicine/article/57010/genitourinary-cancer/fda-approves-abiraterone-use-ahead-prostate-cancer